Fox Jonathan C - Apr 1, 2025 Form 4 Insider Report for Edgewise Therapeutics, Inc. (EWTX)

Role
Director
Signature
/s/ John R. Moore, Attorney-in-Fact for Fox Jonathan C
Stock symbol
EWTX
Transactions as of
Apr 1, 2025
Transactions value $
$0
Form type
4
Date filed
4/3/2025, 06:11 PM
Previous filing
Jun 12, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EWTX Common Stock Award $0 +559 +5.15% $0.00 11.4K Apr 1, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of restricted stock units granted and released to the reporting person on April 1, 2025, as a Quarterly Retainer Award pursuant to Section 2.4 of the Edgewise Therapeutics, Inc. Outside Director Compensation Policy, as amended.